| CXSS2200064 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.2) | New Drug Application | 2022-07-14 | | | | | view |
| CXHL2300221 | 利拉鲁肽注射液 | liraglutide | Injection | Chemical Drugs(2.2) | New Drug Application | 2023-02-15 | | Zhejiang Heze Pharmaceutical Technology Co Ltd | | | view |
| CXSL2400105 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-07 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2200411 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2022-08-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| JYSZ2300038 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2023-09-13 | | | | | view |
| CXSL2400436 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-07-09 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXSL2300092 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-02-08 | | Federal Biotechnology (Zhuhai Hengqin) Co Ltd | | | view |
| CXSL2400082 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-01 | | | | | view |
| CXSL2400772 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-11-13 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXSS2200065 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.2) | New Drug Application | 2022-07-14 | | | | | view |
| CXSS2300067 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-08-22 | | | | | view |
| CXHL2400487 | 利拉鲁肽注射液 | liraglutide | Injection | Chemical Drugs(2.2) | New Drug Application | 2024-05-14 | | Zhejiang Heze Pharmaceutical Technology Co Ltd | | | view |
| CXSS2101025 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2021-09-02 | | | | | view |
| JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | | | | view |
| JYSZ2400055 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2024-10-16 | | | | | view |
| CXSS2200085 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2022-10-21 | | | | | view |
| CXSL2300515 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-07-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| JYSB2400059 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2024-03-14 | | Novo Nordisk A/S | | | view |
| CXSS2101024 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2021-09-02 | | | | | view |
| CYSB2300007 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
